Endogenex, a pioneering clinical-stage medical device company dedicated to transforming diabetes care, has successfully closed an oversubscribed Series C financing round, raising a remarkable $88 million. This substantial funding boost will propel the company towards completing its pivotal ReCET Clinical Study, a critical step in bringing their innovative ReCET™ System to market for patients suffering…
Antiverse, a forward-thinking techbio company focused on antibody design for challenging therapeutic targets, has successfully raised an additional £3.5M ($4.6M) in its latest funding round. This investment elevates the total funding to £7.2M ($10.1M) and will significantly bolster Antiverse’s growth initiatives, including the expansion of its research facilities in Boston and Prague. The funding was…
Saronic, a leader in autonomous surface vessel (ASV) technology, has secured a massive $175 million Series B funding round, propelling the company to a coveted unicorn status with a valuation of $1 billion. This investment, led by Andreessen Horowitz (a16z), will fuel Saronic’s mission to revolutionize naval warfare with its next-generation unmanned technology. Saronic’s ASVs,…
Inscora, an innovative Montreal-based startup specializing in automated cyber risk assessment and sales enablement for cyber insurance brokers, has successfully raised $2 million in its latest funding round. The investment, led by Luge Capital, includes contributions from Desjardins Capital, Accelia Capital, Inovia Capital, and notable angel investors from the cybersecurity sector. Founded by Gabriel Tremblay,…
Shenzhen Synthetica Pioneering Co., Ltd. has successfully concluded a Series A funding round, raising significant capital to propel its innovative oncolytic bacterial therapy into clinical trials. This funding milestone, spearheaded by prominent investors including Boehringer Ingelheim Venture Fund and Temasek, along with contributions from Lenovo Capital, Fosun Health Capital, and ATLATL Summer Fund, underscores the…
In a pivotal move for sustainable transport, Polish firm MMI has secured €7.7 million from the Vinci S.A. fund. This substantial investment will drive MMI’s ambitious plan to transform public transport with a new range of electric and hydrogen-powered minibuses. With this funding, MMI aims to expand its product lineup, enhance technological capabilities, and significantly…
Element Biosciences, a trailblazer in advancing scientific discovery through groundbreaking technologies, has announced a significant milestone in its journey of innovation. The company has successfully raised over $277 million in Series D funding, underscoring its pivotal role in revolutionizing DNA sequencing and multi-omics technologies. This latest round, led by Wellington Management and supported by a…
New Frontier Funding, a trailblazer in utilizing generative AI to facilitate credit and debt funding for small and medium-sized businesses (SMBs), has successfully closed a significant round of growth capital from the Homsher Family Office. The investment underscores the transformative potential of artificial intelligence in addressing the systemic challenge of capital access for businesses. Currently,…
osapiens, a frontrunner in ESG (Environmental, Social, and Governance) compliance and sustainability reporting solutions, has announced the successful closure of a $120 million Series B funding round. The investment was spearheaded by Growth Equity at Goldman Sachs Alternatives, marking a significant milestone for the company. This new capital infusion is set to propel osapiens into…
Kano Therapeutics, a forward-thinking biotechnology firm emerging from MIT, has announced the successful closure of a $7.1 million funding round, underscoring its potential to reshape the landscape of genetic medicine. This financing includes an oversubscribed $5 million seed round co-led by The Engine Ventures and VSquared Ventures, with additional support from Taihill Venture and Metaplanet….
